Adicet Bio, Inc.
ACET
$0.56
$0.023.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 28.50% | -43.88% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -13.71% | 8.39% | |||
| Operating Income | 13.71% | -8.39% | |||
| Income Before Tax | 13.97% | -10.64% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 13.97% | -10.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 13.97% | -10.64% | |||
| EBIT | 13.71% | -8.39% | |||
| EBITDA | 14.18% | -8.98% | |||
| EPS Basic | 13.98% | -10.62% | |||
| Normalized Basic EPS | 13.96% | -10.64% | |||
| EPS Diluted | 13.98% | -10.62% | |||
| Normalized Diluted EPS | 13.96% | -10.64% | |||
| Average Basic Shares Outstanding | 0.00% | 0.02% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||